JAKARTA (Reuters) – Indonesia has approved the single-dose COVID-19 vaccines produced by Janssen Pharmaceutical Companies, part of Johnson & Johnson, and China’s CanSino Biological Inc for emergency use, the country’s food and drug agency said in a statement on Tuesday.
(Reporting by Stanley Widianto; Writing by Gayatri Suroyo; Editing by Ed Davies)
